Skip to main content

Agora
Sign in

Senate bill · S. 4332 (119th Congress)

Medication Competition Act

Latest action Apr 16, 2026

U.S. Senate

Sponsor

Margaret Wood Hassan

U.S. Senator for New Hampshire · Democratic

Follow

Summary

Requires the Secretary of Health and Human Services to determine and specify exclusivity periods for licensed biological products under existing law.

AI summary. Not an official summary. How we handle summaries

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Sign in or create an account to give your position

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

Senate Committee on Health, Education, Labor, and Pensions · U.S. Senate

Cosponsors

Ted Budd

Cosponsors listed on Congress.gov, shown A to Z.

  • Republican1

Shown in neutral colors by design; Agora is non-partisan.

Full history

  1. Apr 16, 2026

    Introduced

    Introduced in U.S. Senate

    U.S. Senate

  2. Apr 16, 2026

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  3. Apr 16, 2026

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  4. Apr 16, 2026

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.